Jian Hong Tao
Director/Board Member at APICHOPE PHARMACEUTICAL CO., LTD
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Yan Qing Zhao | M | 42 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 8 years |
Yong Hui Wang | M | 62 | 27 years | |
Xiao Qin Wang | F | 47 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 6 years |
Chao Yang Zhu | M | 59 | 16 years | |
Han Xiong Li | M | 50 | 22 years | |
Hong Chen | M | 52 | - | |
Xue Qin Deng | M | 57 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 16 years |
Ning Cui | F | 47 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 14 years |
Wei Hua Huang | F | 53 | 19 years | |
Li Xu | M | 37 | 7 years | |
Xiao Dong Zheng | M | 48 | - | |
De Ming Yang | M | 49 | 6 years | |
Hong Zhong Cao | M | 58 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 5 years |
Jiang Tao Bai | M | 47 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 8 years |
Bi Cheng Zhang | M | 58 | - | |
Ji Dong Hu | M | 54 | 7 years | |
Qing Quan Zhou | M | 68 | 5 years | |
Feng Lu | M | 51 | 5 years | |
Zhi Ying Kang | F | 47 | 5 years | |
Jian Guang Zeng | M | 50 | 3 years | |
Nian Yi Ma | M | 48 | 1 years | |
Yan Mao Huang | M | 53 | 1 years | |
Jie Wu | M | 54 | 3 years | |
Wei Yu Xu | M | 39 | - | |
Ju You | F | 44 | - | |
Wen Jie Shen | F | 57 | - | |
Ping Dong Yuan | M | 56 | 8 years | |
Hui Xing Zhang | M | 58 | 16 years | |
Dong Ling Yang | F | 57 | 20 years | |
Zhen Liang | M | 43 | 7 years | |
An Tang | M | 67 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 5 years |
Jing Yu Jin | M | 58 | 3 years | |
Hai Yan Jiang | F | 43 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 6 years |
Xiao Yuan Chen | M | 41 | - | |
Chun Xue Tang | F | 45 | - | |
Zi Yu Mo | M | 67 | 22 years | |
Jian Fei Jia | M | 45 | 3 years | |
Jun Xiong Xiao | M | 51 | 1 years | |
Miao He | F | 39 | - | |
Jin Song Song | M | 57 | 7 years | |
Jun Hui Chen | M | 57 | 12 years | |
Xiang Xing Zeng | M | 42 | 1 years | |
Hao Yun Liu | F | 39 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 1 years |
Xiao Yan Niu | F | 46 | 2 years | |
Feng Wang | F | - | - | |
Xiao Tong Wu | F | 32 | 1 years | |
Quan Bo Zhao | M | 53 | 8 years | |
Wen Jin Chen | M | 51 | 2 years | |
Wen Hui Tan | M | 57 | 14 years | |
Yu Fei Yuan | M | 53 | 6 years | |
Run Mao | M | 58 | 7 years | |
Zhen Hua Ren | M | 51 | 6 years | |
Hua Zhang | M | 51 | 4 years | |
Hong Jie Ma | F | 53 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 5 years |
Ying Ying Zhang | F | 38 | 6 years | |
Rui Yu Ke | F | 39 | 6 years | |
Ming Yuan Zhang | M | 39 | 2 years | |
Pan Yu Wei | F | 34 | - | |
Han Dong Li | M | 56 | 21 years | |
Liang Wen Huang | F | 48 | 17 years | |
Ming Li Wei | M | 43 | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Bin Huang | M | 68 | 23 years | |
Liu Cai Zhong | M | 58 | 6 years | |
Jian Fei Chen | F | 61 | 6 years | |
Hua Bai | M | 55 | 3 years | |
Chun Yan Su | F | 56 | - | |
Xiao Ping Mo | F | 37 | - | |
Chua Chen | M | 61 | 6 years | |
Sheng Jiang | M | 48 | 3 years | |
Kun Song Li | M | 49 | 10 years | |
Hong Long Zhang | M | 43 | 16 years | |
Yu Mei Zhu | F | 49 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 4 years |
Ya Xiao | F | 51 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 3 years |
Jia Wen | F | 45 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
China | 74 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jian Hong Tao
- Personal Network